Cargando…

Co-administration of treatment for drug-resistant TB and hepatitis C

Detalles Bibliográficos
Autores principales:	Olaru, I. D., Beliz Meier, M., Schumacher, S. G., Prodanovic, N., Kitchen, P. J., Mirzayev, F., Denkinger, C. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879085/ https://www.ncbi.nlm.nih.gov/pubmed/36853135 http://dx.doi.org/10.5588/ijtld.22.0403

Ejemplares similares

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Clinical and imaging features of drug-susceptible and multidrug-resistant TB in Korean adults
por: Kim, S-H., et al.
Publicado: (2023)

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
por: Kaniga, K., et al.
Publicado: (2022)

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
por: Millard, James, et al.
Publicado: (2023)

Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date
por: Stancil, Stephani L, et al.
Publicado: (2021)

Pediatric delamanid treatment for children with rifampicin-resistant TB
por: Tyeku, N., et al.
Publicado: (2022)

Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring
por: Huddart, S., et al.
Publicado: (2023)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)

Management of drug-resistant TB in patients with HIV co-infection
por: Meintjes, Graeme
Publicado: (2014)

A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB
por: Memani, B., et al.
Publicado: (2022)

Co-testing a single sputum specimen for TB and SARS-CoV-2
por: Genade, L. P., et al.
Publicado: (2023)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
por: Mohr-Holland, E., et al.
Publicado: (2021)

Oral regimen for multi-drug-resistant TB can promote patient-centred and community-based treatment
por: Saurabh, Suman, et al.
Publicado: (2021)

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
por: Muniyandi, Malaisamy, et al.
Publicado: (2023)

The high costs facing TB-affected households in Mali
por: Traore, M., et al.
Publicado: (2022)

Contribution of Xpert(®) MTB/RIF to pediatric TB diagnosis in Mozambique
por: Mutemba, C. M., et al.
Publicado: (2023)

Prevalence of TB and health-seeking behaviour
por: Conan, N., et al.
Publicado: (2022)

“Upcycling” known molecules and targets for drug-resistant TB
por: Roubert, Christine, et al.
Publicado: (2022)

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
por: Alavian, Seyed Moayed
Publicado: (2015)

Diagnostic performance of the AID line probe assay in the detection of Mycobacterium tuberculosis and drug resistance in Romanian patients with presumed TB
por: Rachow, Andrea, et al.
Publicado: (2022)

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease
por: Mbelele, P. M., et al.
Publicado: (2022)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Household drug-resistant TB contact tracing in Tajikistan
por: Rekart, M. L., et al.
Publicado: (2023)

High prevalence of TB disease in contacts of adults with extrapulmonary TB
por: Wingfield, Tom, et al.
Publicado: (2018)

The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons
por: Wachinger, Jonas, et al.
Publicado: (2021)

PREVALENCE OF TUBERCULOSIS, DRUG-RESISTANT TUBERCULOSIS AND HIV/TB CO-INFECTION IN ENUGU, NIGERIA
por: Ugwu, Kennethe Okonkeo, et al.
Publicado: (2021)

Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
por: Anderson, Timothy S., et al.
Publicado: (2022)

Multidrug-Resistant TB as A Major Concern for Tuberculosis Control Programs
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Lessons from Jonathan Mann: The Ten Commandments on Multidrug-Resistant TB
por: Kirby, Michael
Publicado: (2016)

Use of big data on the social determinants of TB to find the “missing millions”
por: Biermann, O., et al.
Publicado: (2022)

Prevalence of tuberculosis (TB), including multi-drug-resistant and extensively-drug-resistant TB, and association with occupation in adults at Sirindhorn Hospital, Bangkok
por: Mphande-Nyasulu, Fingani Annie, et al.
Publicado: (2022)

Why need for five anti-tubercular drugs in a child with CNS TB?
por: Bagalkot, Praveen S.
Publicado: (2012)

Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
por: Kambili, C., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on TB infection testing
por: Schiza, V., et al.
Publicado: (2022)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

800. Drug-Resistant TB: An Experience From Qatar
por: Ali, Maisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_55uuh6alb0nepdruoii21ohhh5